Issue 26, 2015

Engineering of a lipid-polymer nanoarchitectural platform for highly effective combination therapy of doxorubicin and irinotecan

Abstract

We developed a highly stable lipid-polymer nanoarchitectural platform for effective combination therapy of doxorubicin and irinotecan in the polyelectrolyte complex nanoparticle core, followed by incorporation of the whole assembly into a lecithin bilayer. It shows great potential for the treatment of a broad range of cancers.

Graphical abstract: Engineering of a lipid-polymer nanoarchitectural platform for highly effective combination therapy of doxorubicin and irinotecan

Supplementary files

Article information

Article type
Communication
Submitted
17 Jan 2015
Accepted
18 Feb 2015
First published
19 Feb 2015

Chem. Commun., 2015,51, 5758-5761

Engineering of a lipid-polymer nanoarchitectural platform for highly effective combination therapy of doxorubicin and irinotecan

T. Ramasamy, H. B. Ruttala, J. Y. Choi, T. H. Tran, J. H. Kim, S. K. Ku, H. G. Choi, C. S. Yong and J. O. Kim, Chem. Commun., 2015, 51, 5758 DOI: 10.1039/C5CC00482A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements